Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter‐related infection treated with amikacin.

Autor:	Kojya, Sanae, Shiohira, Hideo, Sunagawa, Yoshitsugu, Tsuneyoshi, Shoji, Kohagura, Kentaro, Ohya, Yusuke, Yonaha, Fusako, Hokama, Nobuo, Nakamura, Katsunori
Předmět:	DRUG monitoring PERITONEAL dialysis MYCOBACTERIAL diseases CATHETER-related infections DRUG side effects PHARMACOKINETICS
Zdroj:	Clinical Case Reports; Jun2020, Vol. 8 Issue 6, p995-998, 4p
Abstrakt:	The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentrations in patients receiving CAPD. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.